A phase I trial of a novel mTOR inhibitor AP23573 administered weekly (wkly) in patients (pts) with refractory or advanced malignancies: A pharmacokinetic (PK) and pharmacodynamic (PD) analysis

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3150-3150 ◽  
Author(s):  
A. A. Desai ◽  
L. Janisch ◽  
L. R. Berk ◽  
H. L. Knowles ◽  
V. M. Rivera ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Mtor Inhibitor ◽  
Advanced Malignancies

scholarly journals A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies

2021 ◽  
Author(s):  
Neel D. Trivedi ◽  
Samantha Armstrong ◽  
Hongkun Wang ◽  
Marion Hartley ◽  
John Deeken ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Mtor Inhibitor ◽  
Advanced Malignancies

Phase I Trial of Intraperitoneal Gemcitabine in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity

2007 ◽  
Vol 13 (4) ◽  
pp. 1232-1237 ◽  
Author(s):  
R. J. Morgan ◽  
T. W. Synold ◽  
B. Xi ◽  
D. Lim ◽  
S. Shibata ◽  
...  
Keyword(s):  
Phase I ◽  
Peritoneal Cavity ◽  
Phase I Trial ◽  
Advanced Malignancies

scholarly journals Phase I Trial of Intraperitoneal Nab-Paclitaxel in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity

2014 ◽  
Vol 25 ◽  
pp. iv159
Author(s):  
M.C. Cristea ◽  
S. Rivkin ◽  
D. Lim ◽  
V. Chung ◽  
J. Chao ◽  
...  
Keyword(s):  
Phase I ◽  
Peritoneal Cavity ◽  
Phase I Trial ◽  
Advanced Malignancies

Phase I Trial of Piritrexim Capsules Using Prolonged, Low-Dose Oral Administration for the Treatment of Advanced Malignancies

1991 ◽  
Vol 83 (1) ◽  
pp. 51-55 ◽  
Author(s):  
L. G. Feun ◽  
N. Savaraj ◽  
P. Benedetto ◽  
J. Hanlon ◽  
K. S. Sridhar ◽  
...  
Keyword(s):  
Oral Administration ◽  
Phase I ◽  
Phase I Trial ◽  
Low Dose ◽  
Advanced Malignancies ◽  
Dose Oral

scholarly journals Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies

2010 ◽  
Vol 46 (2) ◽  
pp. 340-347 ◽  
Author(s):  
Shivaani Kummar ◽  
Martin E. Gutierrez ◽  
Erin R. Gardner ◽  
Xiaohong Chen ◽  
William D. Figg ◽  
...  
Keyword(s):  
Heat Shock ◽  
Heat Shock Protein ◽  
Phase I ◽  
Phase I Trial ◽  
Protein Inhibitor ◽  
Advanced Malignancies

Warburg science goes to the bedside: A phase I trial of 2-deoxyglucose in patients with prostate cancer and advanced malignancies

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 16087-16087
Author(s):  
R. S. DiPaola ◽  
M. N. Stein ◽  
S. Goodin ◽  
S. Eddy ◽  
E. H. Rubin ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Advanced Malignancies

A Phase I Trial of Irinotecan Alternating With Epirubicin in Patients With Advanced Malignancies

2008 ◽  
Vol 31 (5) ◽  
pp. 413-416 ◽  
Author(s):  
Laura W. Goff ◽  
Mace L. Rothenberg ◽  
A Craig Lockhart ◽  
Bruce J. Roth ◽  
Wendy L. VerMeulen ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Advanced Malignancies

Phase I Trial of High-Dose Tamoxifen in Combination with Cisplatin in Patients with Lung Cancer and Other Advanced Malignancies

2003 ◽  
Vol 21 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Edith A. Perez ◽  
David R. Gandara ◽  
Martin J. Edelman ◽  
Robert O'Donnell ◽  
Ignacio J. Lauder ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
High Dose ◽  
Advanced Malignancies
Sign in / Sign up

Export Citation Format

Share Document